| Identification | Back Directory | [Name]
5- (4-methoxy-benzyl)-5H,7H-dibenzo[b,d]azepin-6-one | [CAS]
847926-44-7 | [Synonyms]
5- (4-methoxy-benzyl)-5H,7H-dibenzo[b,d]azepin-6-one
5-[(4-methoxyphenyl)methyl]-7H-benzo[d][1]benzazepin-6-one
6H-Dibenz[b,d]azepin-6-one, 5,7-dihydro-5-[(4-methoxyphenyl)methyl]- | [Molecular Formula]
C22H19NO2 | [MDL Number]
MFCD28387125 | [MOL File]
847926-44-7.mol | [Molecular Weight]
329.39 |
| Chemical Properties | Back Directory | [Boiling point ]
596.6±43.0 °C(Predicted) | [density ]
1.203±0.06 g/cm3(Predicted) | [storage temp. ]
Room Temperature | [solubility ]
Deuterated Chloroform, Methanol | [form ]
Oil | [pka]
0.34±0.20(Predicted) | [color ]
Red |
| Hazard Information | Back Directory | [Uses]
5-(4-Methoxybenzyl)-5H,7H-dibenzo[b,d]azepin-6-one is an intermediate in the synthesis of (S)-7-Amino-5H,7H-dibenzo[b,d]azepin-6-one, a building block for γ-secretase inhibitors for treatment of Alzheimer''s disease. Several γ-secretase inhibitors have been described that contain this compound. |
|
|